# Castle Creek Biosciences

**Canonical:** https://apis.io/providers/castle-creek-biosciences/  
**Website:** https://castlecreekbio.com  
**APIs profiled:** 0

Castle Creek Biosciences is a late‑stage biotechnology company developing autologous fibroblast‑based gene therapies for rare genetic skin disorders such as dystrophic epidermolysis bullosa. The firm conducts a registrational trial of its lead candidate D‑Fi and aims to create transformative, personalized treatments for patients with severe genetic diseases. It operates from Exton, Pennsylvania, and focuses on both ex vivo and in vivo approaches to deliver durable therapeutic outcomes.

## Kin Score — 13.0 / 100 (emerging)

Scored 2026-10-09 under rubric 0.23.0.

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 10.5 |
| Developer Ergonomics | 9.5 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 15.6 (matched via tags).

## Agent readiness — 3.1 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | documented |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (2)

- **Castle Creek Biosciences Domain Security** — TLSv1.3 · HSTS · DNSSEC · DMARC
- **Castle Creek Biosciences Vulnerability Disclosure** — security.txt · contact published

## Tags

Biotechnology, Gene Therapy, Regenerative Medicine, Healthcare, Biotech Company

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/castle-creek-biosciences/). Scores are computed from the provider's own public artifacts under a published rubric.